The Pharmacopoeia Commission for Indian Medicine & Homoeopathy, Ministry of Ayush, successfully conducted a five-day Capacity Building Training Program from September 8 to 12, 2025 at its headquarters in Ghaziabad. The program was aimed at strengthening the regulatory framework, quality assurance, and standardisation processes for Ayurveda, Siddha, Unani, and Homoeopathy drugs.
The training brought together 27 participants from across India, representing regulatory bodies, research councils, pharmaceutical industries, and academic institutions. The comprehensive sessions were designed to equip Drug Enforcement Officers, Quality Control Personnel, and drug manufacturers with advanced knowledge and hands-on experience in pharmacopoeial standards and Good Manufacturing Practices.
The program was inaugurated by Prof. (Vaidya) Rakesh Sharma, Former President, Board of Ethics & Registration, NCISM. Dr. Tarkeshwar Jain, Former President, Homoeopathy Education Board, NCH, graced the occasion as Guest of Honour. The inaugural session was led by Dr. Raman Mohan Singh, Director, PCIM&H.
Program Highlights:
- Days 1 & 2
Technical sessions covered Pharmacognostic Identification, Phytochemical Analysis, and GMP Compliance, along with hands-on training in the Pharmacognosy and Chemistry laboratories. - Day 3:
Lectures focused on Shelf-life Studies and Regulatory Frameworks, followed by industry visits to Dr. Willmar Schwabe India Pvt. Ltd. (Noida) and Hamdard Laboratories (Ghaziabad), offering real-world exposure.
- Day 4:
Sessions included Microbiological & Pharmacological Evaluations, Standardisation of Metal & Mineral Drugs, and Regulatory Aspects. Participants also engaged in laboratory training and visited the on-site Herbal Garden. - Day 5:
Concluding sessions featured discussions on NABL Accreditation, GMP, and the Standardisation of Siddha Drugs.
The valedictory session was graced by Prof. Dr. K. Ramachandra Reddy, Vice Chancellor, Mahayogi Guru Gorakhnath AYUSH University (Chief Guest); Dr. Neelima Mishra, Director, National Institute of Biologicals (Guest of Honour); and Dr. Pankaj Johri, Director, NABP-QCI (Special Guest).
Participants highly appreciated the program’s unique blend of expert-led lectures, practical laboratory sessions, and field visits. The training significantly contributed to enhancing their understanding of Pharmacopoeial Standards, GMP, and Regulatory Compliance, thereby reinforcing the national commitment to ensuring the safety, efficacy, and quality of ASU&H drugs.
